Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | EGFR | P00533 | 1/20 | 0.69 |
| ▸ | SRC | P12931 | 1/20 | 0.69 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.69 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.69 |
| ▸ | CDK2 | P24941 | 1/20 | 0.69 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.69 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.69 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.69 |
| ▸ | RELA | Q04206 | 1/20 | 0.69 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29379310 | 1.00 | TERT (1.00) | TERTKMT2AMEN1EGFRSRC | |
| SCHEMBL34959 | 1.00 | TERT (1.00) | TERTKMT2AMEN1EGFRSRC | |
| SCHEMBL31682981 | 1.00 | TERT (1.00) | TERTKMT2AMEN1EGFRSRC | |
| SCHEMBL9318921 | 0.90 | TERT (0.82) | TERTKMT2AMEN1EGFRSRC | |
| SCHEMBL9318926 | 0.90 | TERT (0.82) | TERTKMT2AMEN1EGFRSRC | |
| SCHEMBL26528874 | 0.88 | TERT (0.78) | TERTKMT2AMEN1EGFRSRC | |
| SCHEMBL30736439 | 0.83 | TERT (0.70) | TERTKMT2AMEN1EGFRSRC | |
| SCHEMBL2541144 | 0.83 | TERT (0.70) | TERTKMT2AMEN1EGFRSRC | |
| SCHEMBL2541146 | 0.83 | TERT (0.70) | TERTKMT2AMEN1EGFRSRC | |
| SCHEMBL31436349 | 0.83 | TERT (0.70) | TERTKMT2AMEN1EGFRSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130189383-A1 | USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | NATIONAL TAIWAN UNIVERSITY (TW) | 2013-07-25 | — | — | US | claimed |
| US-8414936-B2 | Use of Acacia extracts and their compounds on inhibition of xanthine oxidase | NATIONAL TAIWAN UNIVERSITY (TW) | 2013-04-09 | — | — | US | claimed |
| US-20120009288-A1 | USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-01-12 | — | — | US | claimed |
| EP-2034977-B1 | USE OF OPIOID RECEPTOR ANTAGONISTS | DSM IP ASSETS BV (NL) | 2011-07-13 | — | — | EP | claimed |
| US-20100310688-A1 | ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | NATIONAL TAIWAN UNIVERSITY (TW) | 2010-12-09 | — | — | US | claimed |
| US-20090325857-A1 | USE OF OPIOID RECEPTOR ANTAGONISTS | DSM IP ASSETS B.V. (NL) | 2009-12-31 | — | — | US | claimed |
| EP-2034977-A2 | USE OF OPIOID RECEPTOR ANTAGONISTS | DSMIP Assets B.V. (NL) | 2009-03-18 | — | — | EP | claimed |
| US-20090041687-A1 | Use of opioid receptor antagonists | DSM IP ASSETS B.V. (NL) | 2009-02-12 | — | — | US | claimed |
| EP-1926490-A2 | USE OF OPIOID RECEPTOR ANTAGONISTS | DSMIP Assets B.V. (NL) | 2008-06-04 | — | — | EP | claimed |
| WO-2007121916-A2 | USE OF OPIOID RECEPTOR ANTAGONISTS | DSM IP ASSETS B.V. (NL) | 2007-11-01 | — | — | WO | claimed |
| WO-2007039058-A2 | USE OF OPIOID RECEPTOR ANTAGONISTS | DSM IP ASSETS B.V. (NL) | 2007-04-12 | — | — | WO | claimed |
| US-20250281560-A1 | METHOD FOR PREVENTING AND/OR TREATING CANCER OR AUTOIMMUNE DISEASE WITH 3,4,2 Prime,3 Prime,4 Prime-PENTAHYDROXY-TRANS-CHALCONE | NATIONAL CHUNG HSING UNIVERSITY (TW) | 2025-09-11 | — | — | US | disclosed |
| US-20230320957-A1 | COMPOSITION FOR ANTI-AGING OR SKIN REGENERATION COMPRISING ISOPROCURCUMENOL | POSCO CO., LTD (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20230321003-A1 | COMPOSITION FOR ANTI-AGING OR SKIN REGENERATION COMPRISING OKANIN | POSCO CO., LTD (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20230321003-A1 | COMPOSITION FOR ANTI-AGING OR SKIN REGENERATION COMPRISING OKANIN | POSCO CO., LTD (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20090041687-A1 | Use of opioid receptor antagonists | DSM IP ASSETS B.V. (NL) | 2009-02-12 | — | — | US | disclosed |
| CN-101272787-A | Use of opioid receptor antagonists | DSM IP ASSETS BV (NL) | 2008-09-24 | — | — | CN | disclosed |
| EP-1926490-A2 | USE OF OPIOID RECEPTOR ANTAGONISTS | DSMIP Assets B.V. (NL) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007121916-A2 | USE OF OPIOID RECEPTOR ANTAGONISTS | DSM IP ASSETS B.V. (NL) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007039058-A2 | USE OF OPIOID RECEPTOR ANTAGONISTS | DSM IP ASSETS B.V. (NL) | 2007-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230321003-A1 | COMPOSITION FOR ANTI-AGING OR SKIN REGENERATION COMPRISING OKANIN | GLA, KRT18, LIMS1 | TERT 392/4885KMT2A 3654/4885MEN1 4491/4885 |
| US-20120009288-A1 | USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | XDH, AOX1, ACACA | TERT 2205/4885KMT2A 2538/4885MEN1 4855/4885 |
| US-20230320957-A1 | COMPOSITION FOR ANTI-AGING OR SKIN REGENERATION COMPRISING ISOPROCURCUMENOL | EBP, FGF1, IGFBP1 | TERT 100/4885KMT2A 4603/4885MEN1 4722/4885 |
| US-20100310688-A1 | ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | XDH, ACACA, ACAT1 | TERT 2114/4885KMT2A 2609/4885MEN1 4854/4885 |
| US-20130189383-A1 | USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE | XDH, AOX1, ACACA | TERT 2205/4885KMT2A 2538/4885MEN1 4855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.